BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 25921664)

  • 1. Screening and detection of hepatocellular carcinoma.
    Simpson HN; McGuire BM
    Clin Liver Dis; 2015 May; 19(2):295-307. PubMed ID: 25921664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders.
    Wong RJ; Ahmed A; Gish RG
    Clin Liver Dis; 2015 May; 19(2):309-23. PubMed ID: 25921665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Squamous cell carcinoma antigen in hepatocellular carcinoma: Ready for the prime time?
    Montagnana M; Danese E; Lippi G
    Clin Chim Acta; 2015 May; 445():161-6. PubMed ID: 25840050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of biomarkers and imaging in the management of hepatocellular carcinoma.
    Fartoux L; Decaens T
    Clin Res Hepatol Gastroenterol; 2011 Jun; 35 Suppl 1():S21-30. PubMed ID: 21742297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current status and future prospects of biomarkers in the diagnosis of hepatocellular carcinoma.
    Zhao Y; Gao Q; Pei L; Wang C; Jin L; Liao F
    Int J Biol Markers; 2017 Oct; 32(4):e361-e369. PubMed ID: 28967065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnosis of hepatocellular carcinoma: role of tumor markers and liver biopsy.
    Gonzalez SA; Keeffe EB
    Clin Liver Dis; 2011 May; 15(2):297-306, vii-x. PubMed ID: 21689614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human telomerase reverse transcriptase messenger RNA (TERT mRNA) as a tumour marker for early detection of hepatocellular carcinoma.
    El-Mazny A; Sayed M; Sharaf S
    Arab J Gastroenterol; 2014 Jun; 15(2):68-71. PubMed ID: 25097049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha-fetoprotein in hepatocellular carcinoma surveillance: wake not the dead.
    Giannini EG; Farinati F; Trevisani F
    Hepatology; 2011 Jul; 54(1):376-7. PubMed ID: 21710475
    [No Abstract]   [Full Text] [Related]  

  • 9. Hepatocellular carcinoma, a unique tumor with a lack of biomarkers.
    Debes JD; Carrera E; Mattos AZ; Prieto JE; Boonstra A;
    Ann Hepatol; 2019; 18(6):786-787. PubMed ID: 31494068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of PIVKA-II for early hepatocellular carcinoma diagnosis and prediction of microvascular invasion.
    Poté N; Cauchy F; Albuquerque M; Voitot H; Belghiti J; Castera L; Puy H; Bedossa P; Paradis V
    J Hepatol; 2015 Apr; 62(4):848-54. PubMed ID: 25450201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Screening for hepatocellular carcinoma].
    Leone N; Rizzetto M
    Minerva Med; 2005 Apr; 96(2):95-108. PubMed ID: 16172579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, screening, diagnosis and treatment of hepatocellular carcinoma.
    Hussain K; El-Serag HB
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):123-38. PubMed ID: 19305372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of small hepatocellular carcinoma.
    Leoni S; Piscaglia F; Righini R; Bolondi L
    Acta Gastroenterol Belg; 2006; 69(2):230-5. PubMed ID: 16929622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 70-year-old woman with 10 years of markedly elevated alpha-fetoprotein measurements.
    Hsu SX; Siegel AB; Berk PD
    Semin Liver Dis; 2010 Feb; 30(1):99-106. PubMed ID: 20175037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum tests for diagnosis and follow-up of hepatocellular carcinoma after treatment.
    Trojan J; Raedle J; Zeuzem S
    Digestion; 1998 Jul; 59 Suppl 2():72-4. PubMed ID: 9718428
    [No Abstract]   [Full Text] [Related]  

  • 17. [Early diagnosis of hepatocellular carcinoma].
    Hirooka N; Matsuura N; Ohto M
    Nihon Rinsho; 1994 Jan; 52(1):69-74. PubMed ID: 7509420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multivariate analysis of molecular markers in peripheral blood associated with recurrence and metastasis of hepatocellular carcinoma.
    Liu XJ; Wang B; Jiang WG; Li YJ; Liu JB; Zhang M
    Genet Mol Res; 2015 Feb; 14(1):1502-7. PubMed ID: 25730089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma surveillance: An evidence-based approach.
    Harris PS; Hansen RM; Gray ME; Massoud OI; McGuire BM; Shoreibah MG
    World J Gastroenterol; 2019 Apr; 25(13):1550-1559. PubMed ID: 30983815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic value of alpha-fetoprotein, des-γ-carboxy prothrombin and squamous cell carcinoma antigen immunoglobulin M complexes in hepatocellular carcinoma.
    Bertino G; Neri S; Bruno CM; Ardiri AM; Calvagno GS; Malaguarnera M; Toro A; Malaguarnera M; Clementi S; Bertino N; Di Carlo I
    Minerva Med; 2011 Oct; 102(5):363-71. PubMed ID: 22193346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.